Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Neurostimulation Devices Market, and What Factors Will Drive It?
The market for neurostimulation devices has seen a significant expansion recently. The industry’s value is predicted to increase from $6.16 billion in 2024 to $6.86 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%. The expansion during the historic period has been propelled by factors such as chronic pain management, an aging population, increasing awareness and acceptance, and a multidisciplinary approach.
In the upcoming years, the market size of neurostimulation devices is anticipated to witness substantial growth, escalating to $10.68 billion in 2029 with an 11.7% compound annual growth rate (CAGR). The factors contributing to this growth during the predicted period include the adoption of minimally invasive procedures, expansion of emerging markets, regulatory backing and reimbursement, as well as the rise in telehealth and remote monitoring. The forecast period will also see significant trends such as tailored therapeutic interventions, wearable neurostimulation devices, enhancements in programming and connectivity, along with combined therapy approaches.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2539&type=smp
What Are the Core Market Drivers Propelling Growth in the Neurostimulation Devices Industry?
The global increase in elderly population is propelling the growth of the neurostimulation device market. As the population ages, the number of older individuals suffering from various neurobiological disorders is on the rise. For example, the World Health Organization (WHO), a United Nations agency tasked with international public health, stated in October 2022 that by 2050, low- and middle-income countries will be home to 80% of the elderly. Furthermore, it was predicted that the percentage of the global population aged over 60 will almost double, rising from 12% between 2015 and 2050 to 22%.
How Is the Neurostimulation Devices Market Segmented?
The neurostimulation devicesmarket covered in this report is segmented –
1) By Product: Implantable Devices, External Devices
2) By Application: Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease
3) By End User: Hospitals, Rehabilitation Centers, Medical Clinic
Subsegments:
1) By Implantable Devices: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS)
2) By External Devices: Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Cranial Electrotherapy Stimulation (CES) Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=2539&type=smp
Which Regions Are Driving the Next Phase of the Neurostimulation Devices Market Growth?
North America was the largest region in the global neurostimulation devices market in 2024. Asia-Pacific was the second-largest region in the neurostimulation devices market. The regions covered in the neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Neurostimulation Devices Industry?
Innovations are being made in the realm of minimally invasive treatments for a range of neurological disorders. Neurostimulation devices, for example, are being designed to cause as little physical invasion as possible during neurological therapies. One such example is Deep Brain Stimulation (DBS), a surgical procedure that interferes minimally with the body and is used to alleviate the neurological symptoms of Parkinson’s disease, such as tremors, rigidness, and issues with movement control. DBS employs a neurostimulation device, which operates similarly to a heart pacemaker, and uses it to send electrical pulses to a very specific area in the brain that affects the symptoms of Parkinson’s disease. These electric pulses from the DBS device obstruct the activities of these brain circuits, thereby enabling the remaining brain to operate more normally.
View the full report here:
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
How Is the Neurostimulation Devices Market Defined and What Are Its Core Parameters?
Neurostimulation devices are medical instruments used to deliver electrical impulses to specific parts of the nervous system to modulate nerve activity. These devices are commonly implanted in or placed on the body to treat various neurological conditions. Neurostimulation works by altering or blocking pain signals or by stimulating certain neural pathways to restore function. These devices are designed to improve patients’ quality of life by providing targeted and adjustable therapy.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2539
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
